federal_register: 95-10077
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95-10077 | Determination of Regulatory Review Period for Purposes of Patent Extension; SERZONERegister | Notice | The Food and Drug Administration (FDA) has determined the regulatory review period for SERZONE<Register> and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims that human drug product. | 1995-04-24 | 1995 | 4 | https://www.federalregister.gov/documents/1995/04/24/95-10077/determination-of-regulatory-review-period-for-purposes-of-patent-extension-serzoneregister | https://www.govinfo.gov/content/pkg/FR-1995-04-24/pdf/95-10077.pdf | Health and Human Services Department | 221 | The Food and Drug Administration (FDA) has determined the regulatory review period for SERZONE<Register> and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application... |